Research of Nanoparticle Drug Delivery System of Breast Cancer
DOI:
https://doi.org/10.54097/03ddmk58Keywords:
Breast cancer; Radiational therapy; Surgery; Nanoparticles drug delivery system.Abstract
This passage talks about the formation of breast cancer and the traditional treatment of curing breast cancer. Breast cancer is one of the most common cancers all over the world. There are many people died because of this cancer. Now, doctors have several methods to cure this cancer, and the two most common methods are radiation therapy and surgery. Although these methods can cure breast cancer, they have several disadvantages and scientists try to find new ways to cure breast cancer. With the invention of technology, scientists invented the nanoparticle drug delivery system and tried to use nanoparticle drug delivery systems to treat breast cancer. Nanoparticle drug delivery systems also have different ways and limitations in curing breast cancer. The passage talks about three main ways: Liposomal nanoparticles system, Polymer-based nanoparticles system, and Superparamagnetic iron oxide nanoparticles system.
Downloads
References
[1] Kafle, U., Agrawal, S., & Dash, A. K. (2022). Injectable Nano Drug Delivery Systems for the Treatment of Breast Cancer. Pharmaceutics, 14(12), 2783.
[2] Prusty, R. K., Begum, S., Patil, A., Naik, D. D., Pimple, S., & Mishra, G. (2020). Knowledge of symptoms and risk factors of breast cancer among women: a community based study in a low socio-economic area of Mumbai, India. BMC women's health, 20(1), 106.
[3] Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., Liu, B., Lei, Y., Du, S., Vuppalapati, A., Luu, H. H., Haydon, R. C., He, T. C., & Ren, G. (2018). Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes & diseases, 5(2), 77–106.
[4] Ma Kunlong. Short term distributed load forecasting method based on big data. Changsha: Hunan University, 2014.
[5] Tokumaru, Y., Joyce, D., & Takabe, K. (2020). Current status and limitations of immunotherapy for breast cancer. Surgery, 167(3), 628–630.
[6] Tang, X., Loc, W. S., Dong, C., Matters, G. L., Butler, P. J., Kester, M., Meyers, C., Jiang, Y., & Adair, J. H. (2017). The use of nanoparticulates to treat breast cancer. Nanomedicine (London, England), 12(19), 2367–2388.
[7] Barrios C. H. (2022). Global challenges in breast cancer detection and treatment. Breast (Edinburgh, Scotland), 62 Suppl 1(Suppl 1), S3–S6.
[8] Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, et al. Subtypes of Breast Cancer. In: Mayrovitz HN, editor. Breast Cancer [Internet]. Brisbane (AU): Exon Publications; 2022 Aug 6. Chapter 3. Available from: https://www.ncbi.nlm.nih.gov/books/NBK583808/ doi: 10.36255/exon-publications-breast-cancer-subtypesSHI Biao, LI Yu Xia, YU Xhua, YAN Wang. Short-term load forecasting based on modified particle swarm optimizer and fuzzy neural network model. Systems Engineering-Theory and Practice, 2010, 30(1): 158-160.
[9] Karthikeyan Elumalai, Sivaneswari Srinivasan, Anandakumar Shanmugam, Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment, Biomedical Technology,2024, 5, 109-122
[10] Rasool, M., Malik, A., Waquar, S., Arooj, M., Zahid, S., Asif, M., Shaheen, S., Hussain, A., Ullah, H., & Gan, S. H. (2022). New challenges in the use of nanomedicine in cancer therapy. Bioengineered, 13(1), 759–773.
[11] Manzoor, A. A., Lindner, L. H., Landon, C. D., Park, J. Y., Simnick, A. J., Dreher, M. R., Das, S., Hanna, G., Park, W., Chilkoti, A., Koning, G. A., ten Hagen, T. L., Needham, D., & Dewhirst, M. W. (2012). Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer research, 72(21), 5566–5575.
[12] Fulton, M. D., & Najahi-Missaoui, W. (2023). Liposomes in Cancer Therapy: How Did We Start and Where Are We Now. International journal of molecular sciences, 24(7), 6615.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
